The future of molecular oncology looks promising, with ongoing advancements expected to further transform cancer care. The advent of liquid biopsies offers a non-invasive method for monitoring disease progression and treatment response. Furthermore, the exploration of immuno-oncology is opening new avenues for harnessing the immune system to combat cancer. As our knowledge expands, molecular oncology will continue to pave the way for more effective, personalized cancer treatments.
